Neurogene Inc. (NGNE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 41.99 |
| Open | 42.00 |
| Bid | 42.31 x 200 |
| Ask | 43.17 x 100 |
| Day's range | 39.41 - 43.06 |
| 52-week range | 12.20 - 53.00 |
| Volume | |
| Avg. volume | 114,179 |
| Market cap | 552.831M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Neurogene Inc (NGNE) Reports Financial Results for Q4 and Full Year 2023
Key Financials and Clinical Trial Updates Highlighted
- Simply Wall St.
With 32% ownership, Neurogene Inc. (NASDAQ:NGNE) has piqued the interest of institutional investors
Key Insights Significantly high institutional ownership implies Neurogene's stock price is sensitive to their trading...
© 2024 Yahoo. All rights reserved.